Details

Autor(en) / Beteiligte

• Blagodatskikh, K. A
• Evdokimova, M. A
• Agapkina, Yu. V
• Nikitin, A. G
• Brovkin, A. N
• Pushkov, A. A
• Blagodatskikh, E. G
• Kudryashova, O. Yu
• Osmolovskaya, V. S
• Minushkina, L. O
• Kochkina, M. S
• Selezneva, N. D
• Dankovtseva, E. N
• Chumakova, O. S
• Baklanova, T. N
• Talyzin, P. A
• Reznichenko, N. E
• Donetskaya, O. P
• Tereshchenko, S. N
• Krasil'nikova, E. S
• Dzhaiani, N. A
• Akatova, E. V
• Glezer, M. G
• Galyavich, A. S
• Zakirova, V. B
• Koziolova, N. A
• Timofeeva, I. V
• Yagoda, A. V
• Boeva, O. I
• Katel'nitskaya, L. I
• Khorolets, E. V
• Shlyk, S. V
• Volkova, E. G
• Margaryan, M. P
• Guz', I. O
• Konstantinov, V. O
• Timofeeva, N. V
• Sidorenko, B. A
• Zateishchikov, D. A
• Nosikov, V. V

Titel

polymorphisms G(−174)C in IL6 gene and G(−1082)A in IL10 gene are associated with poor outcomes in patients with acute coronary syndrome

Ist Teil von

• Molecular biology (New York), 2010-10, Vol.44 (5), p.741-747

Ort / Verlag

Dordrecht: Dordrecht : SP MAIK Nauka/Interperiodica

Erscheinungsjahr

2010

Quelle

SpringerLink

Beschreibungen/Notizen

• Association between the rates of poor outcomes in the patient cohort with acute coronary syndrome and polymorphisms G(−174)C in the IL6 gene and G(−1082)A in the IL10 gene were determined. In total, 1145 patients hospitalized for coronary artery disease to cardiological hospitals of Moscow, St. Petersburg, Kazan, Chelyabinsk, Perm, Stavropol, and Rostov-on-Don were examined. The mean observation period was 9.10 ± 5.03 months (maximal, 18 months). Analysis of the survival of the patients with acute coronary syndrome that carried allele A has demonstrated that the presence of IL10 gene polymorphism G(−1082)A is associated with more frequent poor outcomes as compared with GG genotype. The survival time to endpoint for the carriers of GA and AA genotypes was 11.68 ± 0.67 months versus 12.69 ± 0.65 months for the carriers of GG genotype in IL10 gene (χ² = 4.13, p = 0.042). As for the IL6 gene polymorphism G(−174)C, survival rate analysis did not detect any significant association with the risk for poor outcome. However, joint analysis of these polymorphisms in both genes has demonstrated that characteristic of the patients with acute coronary syndrome that carry GG genotype of IL6 gene and GA and AA genotypes of IL10 is a higher rate of poor outcomes (time to endpoint, 11.01 ± 1.24 months) as compared with the carriers of IL6 gene CC and CG genotypes and IL10 gene GG genotype (time to endpoint, 13.28 ± 0.83 months (ξ² = 10.23, p = 0.017). These data suggest that the genes IL6 and IL10, whose products are involved in the control of inflammatory response, play an important role by increasing the probability of poor outcomes in the patients with acute coronary syndrome.